Page 8 - Pharma eZine 140828
P. 8


Balancing profitability with patient 





protection: An ethical dilemma






Prescripion drugs are even called ethical drugs in 
Philipp Aeby is CEO of RepRisk AG. Before My book is a icional thriller, but it is based on 
joining RepRisk in 2006, he served in various a real story I came across while working on a the United States. I love that term. I think it really 

managerial posiions at biotech company Amgen global markeing case in the US. The company I’m says a lot.
and worked on a broad range of internaional talking about - I won’t menion any names - knew 

assignments with the Boston Consuling Group. it was selling a drug that would have some very NN: As of March 2014, the pharmaceuical 
Philipp is also the author of the corporate serious side-efects when taken in combinaion industry was one of the top ive most 

thriller, Kolumbianische Scheidung, which with other drugs. I mean very serious side efects. controversial sectors in RepRisk. At the same 
explores the pracical quesions of ethics in But nobody took any acion and it was deinitely a ime, pharmaceuical companies are oten 

the pharmaceuical industry. Philipp spoke to source of inspiraion for my book.
championed as being in a unique posiion to 
RepRisk Senior Analyst Nicole Neghaiwi about improve the health and welfare of people around 

his experiences with environmental, social and NN: Is that why you decided to move into ESG? the world. Why do you think this sector has been 
governance (ESG) issues in the pharmaceuical such a polarizing force?

industry.
PA: As a climatologist, I was always interested

in the environment. But of course I frequently
PA: Personally I have a very strong opinion 
Nicole Neghaiwi (NN): In 2009, you published a encountered ethical quesions while working in
about this that my former colleagues in the 

icional thriller about drug tesing in Colombia. the pharmaceuical industry, and this intrigued
pharmaceuical industry won’t necessarily agree 
What inspired you to write Kolombianische me. I do think there is a strong link between the
with in public. I believe that the fundamental 

Scheidung?
pharmaceuical industry and ethics - simply based
mistake pharmaceuical companies make from a 
on the fact that - to quote the slogan of my former
public relaions perspecive is that they claim to 

Philipp Aeby (PA): I personally stumbled across employer - it drasically impacts our lives. No
focus on paients’ needs while they are and should 
the quesion of ethics when I was working as a other industry has that kind of power over life and
be commercial operaions. This isn’t a bad thing.

consultant for Big Pharma companies.
death. “Thereisnothingwrongwithpursuingproitsin
order to foster innovaion.





The company knew


it was selling a drug 


that would have some 


very serious side- 


efects when taken in 


combinaion with


other drugs.

I mean very serious 


side-efects.


But nobody took any 


acion and that was ”


deinitely a source of 

mi
inspiraion for my book.
ma
am
mh



8 INSIGHT


   6   7   8   9   10